First-in-Human, Multiple Part Clinical Study of JNT-517 in Healthy Participants and in Participants With Phenylketonuria

Condition:   Phenylketonuria Interventions:   Drug: JNT-517 Suspension;   Drug: Placebo Suspension;   Drug: JNT-517 Tablet;   Drug: Placebo Tablet Sponsor:   Jnana Therapeutics Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials